Home > News > Recent cases

Regeneron v Kymab [2020] UKSC 2724 June 2020Michael Tappin QC, along with Iain Purvis QC, appeared on behalf of the Appellant in this appeal to the Supreme Court involving the patent issue of sufficiency. The Supreme Court allowed Kymab’s appeal by a majority of four to one, holding that Regeneron’s patents were invalid. The patents concerned a new type of genetically modified […]
Les Grands Chais de France SAS v Consorzio di Tutela della Denominazione di Origine Controllata Prosecco [2020] EWHC 1633 (Ch)24 June 2020Fiona Clark appeared for the Respondent (“the Consorzio”) on this appeal against a hearing officer’s refusal to register the sign NOSECCO in respect of non-alcoholic sparkling wine and also at the hearing below. The Consorzio, an association established, inter alia, to protect the well known PROSECCO designation of origin (“the PDO”), had opposed the registration. […]
Teva v Chiesi Farmaceutici [2020] EWHC 1311 (Pat)2 June 2020Charlotte May QC appeared for the defendant in this strike out application. The claimant sought to revoke three patents held by the defendant and the defendant counterclaimed for infringement on a quia timet basis. When the defendant requested disclosure in relation to the allegedly infringing product, the claimant applied to strike out the infringement claim […]
Genentech and MDC -v- The Comptroller General of Patents [2020] EWCA Civ 47531 March 2020Andrew Lykiardopoulos QC appeared for Genentech and Charlotte May QC appeared for Master Data Center (“MDC”) in these two appeals against a decision of Mr Recorder Douglas Campbell QC (sitting as Judge of the Patents Court) refusing to allow the patentee’s supplementary patent certificate (“SPC”) to continue in force beyond the two-year period mistakenly applied […]
Abbott v Edwards Lifesciences [2020] EWHC 513 (Pat)12 March 2020Richard Meade QC, James Abrahams QC, Michael Conway, and Jennifer Dixon appeared for the claimants in this trial concerning the public interest defence to patent infringement. The trial followed the main patent trial in the case (1) Evalve Inc (2) Abbott Cardiovascular Systems Inc (3) Abbott Medical Uk Ltd V Edwards Lifesciences Ltd [2020] EWHC […]